EXEL

Exelixis, Inc. NMS · EXEL

$56.12 +0.59 (+1.06%)

Neutral · +0.76σ

+ Compare Open in Sniper

Valuation

Market cap $14.1B

P/E (ttm) 18.4

Forward P/E 14.2

Beta (5y) 0.42

Shares out 251.4M

Div yield —

Profitability & returns

ROE 41.0%

Net margin 35.1%

FCF margin 26.5%

Debt / equity 0.09

Trading information

Last price $56.12

Day range $55.08 – $56.44

52-wk range $39.71 – $57.57

Avg volume 2.7M

RSI (2) 74.4

Trend zone Neutral

52-week range · today's price

$39.71$57.57

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-04

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOME…